IP Library Granted Patent US 9,005,308
Granted Patent B2
US 9,005,308 · App. 13/650,263 · Granted Apr 14, 2015

Implantable film/mesh composite for passage of tissue therebetween

Inventors: Joshua Stopek (Guilford, CT); Amin Elachchabi (Hamden, CT); Daniel Broom (Branford, CT)
Assignee: Covidien LP
A61F2/0063B32B9/02B32B9/045B32B9/047B32B27/12B32B3/266B32B3/28A61F2250/0031B32B2307/7163B32B2535/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,005,308
App. No.
13/650,263
Granted
Apr 14, 2015
Kind
B2
Abstract

The present disclosure relates to implantable medical devices which include at least one mesh and at least one film attached to the mesh along different portions of the mesh creating at least one aperture between the mesh and the film.

Claims (28)

1. An implantable medical device comprising:

a surgical mesh having a top surface;

a first film having a first outer edge and a first inner edge, the first outer edge attached to a first portion of the top surface of the surgical mesh; and,

a second film having a second outer edge and second inner edge, the second outer edge attached to a second portion of the top surface of the surgical mesh, wherein the first inner edge of the first film and the second inner edge of the second film overlap.

2. The implantable medical device of claim 1 wherein the mesh comprises a bioabsorbable material.

3. The implantable medical device of claim 1 wherein the mesh comprises a non-bioabsorbable material selected from the group consisting of polypropylene, polyethylene terephthalate, expanded polytetrafluoroethylene, condensed polytetrafluoroethylene and combinations thereof.

4. The implantable medical device of claim 1 wherein the mesh comprises polypropylene.

5. The implantable medical device of claim 1 wherein the mesh comprises polyethylene terephthalate.

6. The implantable medical device of claim 1 wherein at least one of the first and second films comprises a bioabsorbable material.

7. The implantable medical device of claim 1 wherein at least one of the first and second films comprises a bioabsorbable material selected from the group consisting of aliphatic polyesters, polyamides, polyamines, polyalkylene oxalates, poly(anhydrides), polyamidoesters, copoly(ether-esters), poly(carbonates), poly(hydroxyalkanoates), polyimide carbonates, poly(imino carbonates), polyorthoesters, polyoxaesters, polyphosphazenes, poly (propylene fumarates), polyurethanes, polymer drugs, and copolymers, block copolymers, homopolymers, blends, and combinations thereof.

8. The implantable medical device of claim 1 wherein at least one of the first and second films comprises a copolymer of glycolide and caprolactone.

9. The implantable medical device of claim 1 wherein at least one of the first and second films comprises a copolymer of glycolide, trimethylene carbonate, caprolactone and lactide.

10. The implantable medical device of claim 1 wherein at least one of the first and second films comprises a copolymer of glycolide, dioxanone and trimethylene carbonate.

11. The implantable medical device of claim 1 wherein at least one of the first and second films comprises collagen.

12. The implantable medical device of claim 1 wherein at least one of the first and second films comprises an anti-adhesion barrier.

13. The implantable medical device of claim 1 wherein the second outer edge of the second film is positioned on the same side of the mesh as the first outer edge of the first film.

14. The implantable medical device of claim 1 wherein the second film layer is positioned on a side of the mesh opposite the first film layer.

15. The implantable medical device of claim 1 further comprising at least one therapeutic agent.

16. The implantable medical device of claim 15 wherein the at least one therapeutic agent comprises a drug selected from the group consisting of lidocaine, bupivicaine, tetracaine, procaine, dibucaine, sirolimus, taxol, chlorhexidine, polyhexamethylene, thiamylal sodium, thiopental sodium, ketamine, flurazepam, amobarbital sodium, phenobarbital, bromovalerylurea, chloral hydrate, phenytoin, ethotoin, trimethadione, primidone, ethosuximide, carbamazepine, valproate, acetaminophen, phenacetin, aspirin, sodium salicylate, aminopyrine, antipyrine, sulpyrine, mepirizole, tiaramide, perixazole, diclofenac, anfenac, buprenorphine, butorphanol, eptazocine, dimenhydrinate, difenidol, dl-isoprenaline, chlorpromazine, levomepromazine, thioridazine, fluphenazine, thiothixene, flupenthixol, floropipamide, moperone, carpipramine, clocapramine, imipramine, desipramine, maprotiline, chlordiazepoxide, clorazepate, meprobamate, hydroxyzine, saflazine, ethyl aminobenzoate, chlorphenesin carbamate, methocarbamol, acetylcholine, neostigmine, atropine, scopolamine, papaverine, biperiden, trihexyphenidyl, amantadine, piroheptine, profenamine, levodopa, mazaticol, diphenhydramine, carbinoxamine, chlorpheniramine, clemastine, aminophylline, choline, theophylline, caffeine, sodium benzoate, isoproterenol, dopamine, dobutamine, propranolol, alprenolol, bupranolol, timolol, metoprolol, procainamide, quinidine, ajmaline, verapamil, aprindine, hydrochlorothiazide, acetazolamide, isosorbide, ethacrynic acid, captopril, enalapril, delapril, alacepril, hydralazine, hexamethonium, clonidine, bunitrolol, guanethidine, bethanidine, phenylephrine, methoxamine, diltiazem, nicorandil, nicametate, nicotinic-alcohol tartrate, tolazoline, nicardipine, ifenprodil, piperidinocarbamate, cinepazide, thiapride, dimorpholamine, levallorphan, naloxone, hydrocortisone, dexamethasone, prednisolone, norethisterone, clomiphene, tetracycline, methyl salicylate, isothipendyl, crotamiton, salicylic acid, nystatin, econazole, cloconazole, vitamin B 1 , cycothiamine, vitamin B 2 , vitamin B 3 , vitamin B 5 , vitamin B 6 , vitamin B 7 , vitamin B 9 , vitamin B 12 , vitamin C, nicotinic acid, folic acid, nicotinamide, calcium pantothenate, pantothenol, panthetin, biotin, ascorbic acid, tranexamic acid, ethamsylate, protamine, colchicine, allopurinol, tolazamide, glymidine, glybuzole, metoformin, buformin, orotic acid, azathioprine, lactulose, nitrogen mustard, cyclophophamide, thio-TEPA, nimustine, thioinosine, fluorouracil, tegafur, vinblastine, vincristine, vindesine, mitomycin C, daunorubicin, aclarubicin, procarbazine, cisplatin, methotrexate, benzylpenicillin, amoxicillin, penicillin, oxycillin, methicillin, carbenicillin, ampicillin, cefalexin, cefazolin, erythromycin, kitasamycin, chloramphenicol, thiamphenicol, minocycline, lincomycin, clindamycin, streptomycin, kanamycin, fradiomycin, gentamycin, spectinomycin, neomycin, vanomycin, tetracycline, ciprofloxacin, sulfanilic acid, cycloserine, sulfisomidine, isoniazid, ethambutol, acyclovir, gancyclovir, vidabarine, azidothymidine, dideoxyinosine, dideoxycytosine, morphine, codeine, oxycodone, hydrocodone, cocaine, pethidine, fentanyl, polymeric forms of any of the above drugs and any combinations thereof.

17. The implantable medical device of claim 15 wherein the at least one therapeutic agent comprises bupivacaine and bupivacaine hydrochloride.

18. The implantable medical device of claim 1 wherein the mesh further comprises at least grip member.

19. The implantable medical device of claim 1 wherein the mesh comprises an animal-derived tissue.

20. The implantable medical device of claim 1 , wherein the mesh comprises an allograft or a xenograft.

21. An implantable medical device comprising:

a surgical mesh having a top surface;

a first film having a first outer edge and a first inner edge, the first outer edge attached to a first portion of the top surface of the surgical mesh;

a second film having a second outer edge and second inner edge, the second outer edge attached to a second portion of the top surface of the surgical mesh, wherein the first inner edge of the first film and the second inner edge of the second film overlap; and,

an aperture positioned between the surgical mesh and a portion of at least one of the first and second films.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2012
From: STOPEK, JOSHUA; ELACHCHABI, AMIN; BROOM, DANIEL
To: COVIDIEN LP
Reel/Frame 029538/0961 →
Continuity (2)
Provisional Application 61551121 · Oct 25, 2011
Related Publication 20130184722A1 · Jul 18, 2013